, sulfonamides have been show-n to reduce the effective vitamin intake of animals by suppressing the intestinal flora, and this reduction of essential vitamins in the diet of tumor-bearing mice is known to inhibit the growth of tumors (Boyland, 1938) . Ray and Soffer (1950) proposed the incorporation of S35 into these compounds. This short-range beta emitter would not only exert possible additional therapeutic effects, but would also offer a means of detection.
INVESTIGATIONS conceming the possible localization of radio-active-labeled dyes in tumors have show-n that some of these compounds tend to concentrate in vital organs to a greater extent than in cancerous tissue. Thus Br82 and I131 derivatives of Evans Blue and Trypan Blue, when administered to tumor-bearing mice, localized in the neoplasm to a greater extent than in skeletal muscle or skin, but considerably less than in liver, spleen or kidneys (Moore, Tobin and Aub, 1943 ;  Stevens, L'ee, Stewart, Quinlin and Gilson, 1949) .
If a compound could be found which would display a greater affinity for the tumor than for such vital organs as the liver and kidneys, whfle at the same time maintaining a favorable ratio of concentrations in tumor and surrounding tissue, it would greatly increase the chances of accurate diagnosis and therapy of internal cancer.
Several characteristics of the sulfonamido linkage endow sulfonamides with diagnostic and therapeutic potentialities. So far as could be found in the literature, the work of Ray and Argus (1951) describes the only case of in vivo hydrolysis of a sulfonamido linkage and this hydrolysis occurred to the extent of only 0-5 per cent. The azo linkage which occurs in Evans Blue and Trypan Blue is quite susceptible to enzymatic fission. In addition to locahzing in certain tissues (Bloch, Schiff, Fleming, Shapiro and Steinberg, 1945 ; Stevens, Quinlin, Meinken and Kock, 1950) , sulfonamides have been show-n to reduce the effective vitamin intake of animals by suppressing the intestinal flora, and this reduction of essential vitamins in the diet of tumor-bearing mice is known to inhibit the growth of tumors (Boyland, 1938) . Ray and Soffer (1950) proposed the incorporation of S35 into these compounds. This short-range beta emitter would not only exert possible additional therapeutic effects, but would also offer a means of detection.
Recent distribution studies in tumor-bearing mice with disodium fluorene-2,7-disulfonate-S35 (Argus, 1953) revealed that the ratios of locahzation in tumor tissue compared to the liver, kidneys, spleen, blood and muscle for this compound were greatly increased over similar values obtained for dyes. Thus this fluorene compound offered a promising basis upon which to build sulfonamido derivatives for localization studies. In the present study, therefore, the following compounds were prepared: fluorene-2,7-disulfo'amide-S35 (I) ; n fluorene-2,7-di-(sulfonamido-2 -naphthalene)-S35 (II) ; and a sulfonated derivative of fluorene-2,7-di-(sulfonamido-2'-naphthalene)-S35 (III). In addition to following the distribution of each of these sulfonamides in tumor-bearing mice, Compound II was also studied i control (non-tumor) Sulfonated derivative offluorene-2,7-di-(sulfonamido-2'-naphthalene)-S35 (III).-To fluorene-2.7-di-(sulfonamido-2'-naphthalene)-S-35, 0-5 g. (0-9 milhmoles), suspended in 5 ml. chloroform was added with shaking C'hlorosulfonic acid, 0-22 ml.
(3-4 millimoles), in 5 ml. chloroform. The reaction mixture was allowed to stand at room temperature for 40 used for each determination. The animals were etherized just prior to sacrifice and blood removed from the aorta at the iliac bifurcation, using a heparinized syringe. The concentration of radio-active material was determined in each of the following tissues : tumor, liver, spleen, kidneys, stomach with contents, intestine with contents, leg muscle, and subaxillary skin from the side opposite the tumor. Planchets of these samples were prepared and counted as described previously (Argus, 1953 (Argus, 1953 An even greater contrast was obtained with fluorene-2,7-di-(sulfonamido-2'-naphthalene)_S35 (Group IIa). Here the concentration of compOund in the tumor was at all times less than that found in any other tissue analysed. A comparison of the concentrations of radio-activity in the blood of the animals of Group IIa at the different time intervals showed a greater amount of activity in the blood at 8 hours than at 2 hours. Since the compound was administered intravenously, the data indicate a return to the blood of the compound or a metabolite at some time after the initial uptake of compound from the blood.
The animals in Group Ilb, differed from those in Group IIa only in that the former received an intraperitoneal injection of glucose prior to the administration of fluorene-2,7-di-(sulfonamido-2'-naphthalene)-S35. This was done i-n the hopes of improving the localization of radioactive compound in the tumor, by decreasing the pH of this tissue. A comparison of the data in Table I for these two groups, however, does not reveal any substantial differences in the distribution of radioactivity. Thus, if the pH of the neoplasm was decreased, the solubility of the disulfonamide at the lower pH was not sufficiently different from that at the usual tumor pH to bring about increased localization.
Contrasts do exist between the distribution data for Group IIc and Group lIa, indicating a difference in the metabolic process of tumor-bearing mice compared to non-tumor-bearing mice receiving the same compound. The disulfonamide was concentrated in the liver and spleen of the control animals (Group Ilc) to a greater extent than in these organs in the mice with tumors at 2, 8, and 32 hours. The concentration of radioactivity in the liver of the control mice at 8 hours was almost twice that in the tumor-bearing mice, while the spleen of the controls held over three times as much compound as did the spleen of the animals of Group Ila. Although the spleens of the tumor hosts were slightly enlarged, bistological examination did not reveal any pronounced differences in the livers and spleens of the tumor mice compared with those of control mice. The contrast in localization of labeled disulfonamide which exists indicates that the presence of a tumor in the animal body has affected some mechanism in these vital organs. Since, in the present study, this.difference could be measured while no changes were evident microscopically, a possible diagnostic tool is suggested.
Comparing the blood data for Group Ila and Group llc, the values for the non-tumor animals present a more reasonable picture inasmuch as the highest activity was found at 2 hours followed by successively decreasing concentrations at the longer time intervals. The total amount of compound accounted for at 2 hours in the control mice was significantly greater than that found in tumorbearing mice at the same time (72-8 per cent of the administered dose as compared to 46-6 per cent). This increased recovery for the animals of Group lIc was due chiefly to the greater concentrations in the liver, spleen and blood. At 8 and 32 hours no particular difference in the total recovery existed.
In the present study the best results with respect to tumor localization were obtained with the sulfonated derivative of fluorene-2 7-di-(sulfonamido-2 naphthalene)-S35(Group III). At each time-period studied a greater concentration of this compound was found in tumor tissue than for the other compounds tested. For the animals of Group 111, the localization in the tumor tissue at 8 hours was greater than that in the leg muscle and spleen, while at 32 hours the concentration of radioactive compound in the neoplasm was greater than that in any of the tissues analysed. These data, together with those obtained previously with fluorene-2,7-disulfonic acid (Argus, 1953) , suggest that the presence of sulfonic acid groups in a molecule offers a better chance for tumor localization.
Favorable locahzation appears to be due in part to the solubihty of the compound. This difference in solubility is also reflected in the rapidity of elimination of the compound from the animal body. Chemical studies revealed fluorene-2,7-di-(sulfonamido-2'-naphthalene)-S-35 to possess a slightly greater solubility than fluorene-2,7-di-sulfonamide-S'-15 (Group 1). In Ene with this, at 32 hours the total amount of compound accounted for in animals receiving the' naphthalene derivative was substantially greater than that found in the animals of Group 1. The even more soluble sulfonic acid compound (Group III) was eliniinated most rapidly, the difference in total amount remaining in the animals be'mg marked as early as 8 hours.
The size of the molecule is also to be considered. The sulfonic acid investigated in the present study (Group III) was a much larger molecule than the fluorene-2,7-disulfonic acid studied previously (Argus, 1953) . Inasmuch as increasing the molecular weight did not increase tumor locahzation, the authors feel that an aromatic sulfonic acid of lesser molecular weight than fluorene-2,7-disulfonic acid should be investigated. SUMMARY.
Syntheses are described for fluorene-2,7-disulfonamide-S'15 J) ; fluorene-2,7-di-(sulfonamido-2'-naphthalene)-S35 (II); and a sulfonated derivative of fluorene-2,7-di-(sulfonamido-2'-naphthalene)-S'-15 (III) . The distribution of radioactivity in the tissues of tumor-bearing mice following a single injection of each of these compounds was stuclied at 2-, 8-, and 32-hour intervals. In addition, Compound (H) was also traced in non-tumor mice and in tumor mice previously injected with glucose. Differences in the metabohc process of tumor-bearing and tumorfree mice were suggested. The most favorable tumor localization was obtained with the sulfonated derivative.
